论文信息 - A phase II study of paclitaxel (P) and carboplatin (C) as second-line treatment in patients (PTS) with small-cell lung cancer (SCLC) - 字舞流文

A phase II study of paclitaxel (P) and carboplatin (C) as second-line treatment in patients (PTS) with small-cell lung cancer (SCLC)

S. Agelaki | V. Georgoulias | G. Samonis | S. Kakolyris | C. Kouroussis | X. Tsiafaki | M. Agelidou | G. Bla-zogiannakis | Th. Palamidas | Ch. Malliotakis